Iteos Therapeutics stock hits 52-week low at $8.39 By Investing.com
Iteos Therapeutics Inc. (NASDAQ: ITOS) stock has reached a 52-week low, trading at $8.39. This latest price point marks a significant downturn for the biotechnology company, which specializes in developing cancer immunotherapies. Over the past year, Iteos Therapeutics has seen its stock value decrease by 15.09%, reflecting investor concerns and a challenging market environment for … Read more